# Object Chain Viewer — case_01_electroculture

> _Step 1 → 2 → 4 → 6 → 7 → 8 → 9 chain. Renders the chain so the reader sees whether drift happened. Does NOT claim drift. See [notes/elif_post_e2_object_drift_audit.md] for the audit that motivated this Panel._


---


## Anchor — Input Frame (verbatim)

> **Reading lens:** _The object as posed in the input frame — the deployment proposal received from the operator._

```
# Case 01 — Input Frame

**Status:** LOCKED 2026-05-28 (re-execution authorization; supersedes original Round 7 documentation).
**Authored by:** operator (substantive doctrinal act).
**Doctrinal scope tag:** scientific-evidential ambiguity (Cluster A per cross-case audit) — weak / inconsistent evidence as the load-bearing feature.
**Independence note:** original Round 7 run preceded procedure v1.0 and was human-executed Condition C. This re-execution applies procedure v1.0 under E1.5 (procedure-augmented LLM) for matching evidence structure with Cases 02 and 03.

**Discipline:**
- The text below is the **verbatim input frame**. It is the `input_frame` field of benchmark template v1.0.
- All three conditions (A: bare LLM / B: structured prompt / C: ELIF-mode procedure v1.0) receive THIS TEXT and only this text.
- No ELIF vocabulary embedded — case arrives in its native scientific / agricultural / public-funding language.
- The if-yes / if-no closure is a structured policy-question shape, not ELIF scaffolding. Condition C may legitimately refuse or reformulate the binary via procedure Step 1.

---

## Verbatim input frame

A coalition of agricultural researchers, environmental agencies, and private agritech companies is considering launching a large-scale research and pilot deployment program around electroculture techniques across several drought-prone agricultural regions.

The proposed systems include:

- passive atmospheric antennas,
- copper-based field devices,
- weak electrical stimulation of crops,
- electrically treated irrigation systems,
- soil conductivity modulation,
- and bioelectrical stimulation of plant growth.

Supporters argue that:

- conventional agriculture is reaching ecological and energetic limits,
- some experimental studies suggest electrical stimulation may improve stress resilience, germination, or nutrient uptake,
- and even modest improvements could significantly improve food resilience under climate instability.

Critics argue that:

- most evidence remains weak or inconsistent,
- many electroculture claims resemble pseudoscience,
- long-term ecological effects are unknown,
- farmers could be pushed into costly and unproven systems,
- and resources may be diverted away from better-established agricultural interventions.

A proposal is now under review to authorize publicly funded pilot programs and limited field deployment over the next five years.

Should the program proceed?

If yes:

- under what constraints,
- at what scale,
- with what validation requirements,
- and with what governance safeguards?

If no:

- what alternative research or agricultural pathways should be prioritized instead?

---

## Cross-references

- `procedure/elif_mode_procedure_v1.0.md` — procedure executed for Condition C.
- `procedure/benchmark_template.md` — capture template (v1.0) for all three conditions.
- `results/case_01/` — destination for Condition A/B/C outputs (created by this re-execution).
- Original Round-7 documentation (pre-v1.0) — see `cases/case_01_electroculture/README.md` for historical reference.
```


---


↓

## Step 1 — Frame Validation

> **Reading lens:** _The object as Step 1 (FrameValidator) reformulates it._

- **verdict:** `needs_decomposition`
- **reformulated_frame:** The composite frame must be decomposed into the following sequence of individually decidable sub-frames, to be executed in dependency order:

**Sub-frame 1 (Evidentiary Threshold — prerequisite to all others):**
Does the existing body of evidence for electroculture techniques (across the six listed system types) meet a minimum threshold of scientific credibility and consistency sufficient to justify expenditure of public research funds on pilot deployment — as distinct from purely exploratory laboratory or literature-review work?

**Sub-frame 2 (Program Authorization — contingent on Sub-frame 1 returning affirmative):**
Given that the evidentiary threshold in Sub-frame 1 is cleared, should a publicly funded pilot deployment program be authorized? This sub-frame takes the evidence quality as an established input and focuses solely on the authorization decision.

**Sub-frame 3 (Program Design Constraints — contingent on Sub-frame 2 returning affirmative):**
If a program is authorized, what are the required constraints on scale, validation methodology, and governance safeguards? Note: this sub-frame should further decompose scale, validation, and governance into separate passes if those dimensions conflict.

**Sub-frame 4 (Counterfactual Prioritization — contingent on Sub-frame 1 or Sub-frame 2 returning negative):**
If the program is not authorized, what alternative research or agricultural intervention pathways should be prioritized with the resources that would otherwise have been committed?

Each sub-frame should also specify which of the six electroculture system types it applies to, as the evidentiary bases and risk profiles may differ materially across passive atmospheric antennas, copper-based field devices, weak electrical crop stimulation, electrically treated irrigation, soil conductivity modulation, and bioelectrical plant stimulation. Sub-frame 1 may require one pass per system type before a composite threshold judgment is issued.
- **reasoning:** The input frame bundles at least three structurally distinct decisions that cannot be resolved by a single binary verdict without conflating separate questions:

1. **Evidentiary threshold decision** — Is the existing evidence base for electroculture techniques sufficient to justify any publicly funded action at all? This is a prior, gatekeeping question that must be settled before downstream decisions are meaningful. The frame acknowledges the evidence is weak and inconsistent (doctrinal scope tag: scientific-evidential ambiguity, Cluster A), which means this sub-question is load-bearing and must be resolved first.

2. **Program authorization decision (conditional on (1))** — If the evidentiary threshold is cleared, should a publicly funded pilot program be authorized? This carries its own decision structure: scale, constraints, validation requirements, and governance safeguards. These are themselves four distinguishable sub-questions that compound the bundling problem.

3. **Counterfactual resource-allocation decision (conditional on rejection in (1) or (2))** — If the program should not proceed, what alternative research or agricultural pathways should be prioritized? This is a wholly separate decision frame with a different option space, different stakeholders, and different evaluation criteria.

The single "Should the program proceed? If yes… If no…" surface form creates the appearance of a binary, but the if-yes branch immediately spawns four further under-determined sub-questions (constraints, scale, validation, governance), and the if-no branch spawns an open-ended prioritization problem. Neither branch is individually decidable as posed. Additionally, the six listed electroculture system types are treated as a single monolithic intervention, when their evidentiary bases and risk profiles may differ materially — this further compounds the frame.

Proceeding to reasoning on this composite frame would risk conflating the evidentiary question with the authorization question, and would allow a weak answer to one to substitute for a missing answer to another. Article II requires the frame to be well-posed before reasoning proceeds.


---


↓

## Step 2 — Object Decomposition

> **Reading lens:** _The object as a partition across decomposition axes._

- **Evidential Status** — families: E1, E2, E3
- **Intervention Mechanism** — families: M1, M2, M3, M4
- **Resource-Allocation Trade-off** — families: R1, R2, R3


---


↓

## Step 4 — Hypotheses with Distinguishing Predictions

> **Reading lens:** _The object as claims (hypotheses) about its outcomes._

- **H1**: 
  _prediction:_ Studies using controlled experimental designs will show a statistically significant dose-response relationship between M1 activation intensity and the primary outcome, a pattern absent under E2 or E3 evidential conditions.
- **H2**: 
  _prediction:_ When M3 pathway activity is experimentally blocked, the outcome association will attenuate to non-significance in E2-class studies while remaining significant in E1-class studies, distinguishing this hypothesis from H1.
- **H3**: 
  _prediction:_ Across study sites stratified by resource level, M2 mechanism fidelity scores will mediate the relationship between funding adequacy and outcomes, and this mediation will be statistically significant only in the R2 stratum, not in R1 or R3 strata.
- **H4**: 
  _prediction:_ In head-to-head comparisons, E3+M4+R3 implementation arms will produce outcome effect sizes statistically non-inferior to E1+M1+R1 arms, a result that would falsify the assumption that evidential grade alone determines effectiveness.


---


↓

## Step 6 — Multi-scale Relations

> **Reading lens:** _The object as a system traced across scales._

**Scales:**
- study/trial scale (individual experimental unit: single RCT, cohort, or mechanistic assay — where E1/E2/E3 evidential families are generated and M1–M4 intervention mechanisms are tested)
- meta-analytic / research-synthesis scale (aggregated body of evidence across studies — where evidential status families E1–E3 are weighted, pooled, and adjudicated)
- clinical / practitioner scale (individual patient or treatment episode — where M1–M4 mechanisms are deployed and R1–R3 resource trade-offs are felt in real time)
- health-system / institutional scale (hospital, insurer, guideline body — where R1–R3 allocation families govern policy, coverage, and protocol adoption)
- research-system / funding scale (grant agencies, priority-setting bodies — where investment in E1 vs. E2 vs. E3 evidential families is decided, shaping which M-families ever get tested)

**Cross-scale relations:**
- E1 (direct experimental evidence) at the study/trial scale does not aggregate cleanly to E3 (real-world effectiveness evidence) at the meta-analytic scale, because internal-validity controls that generate E1 systematically exclude the population heterogeneity that E3 must represent — meaning pooled E1 findings can overstate or misstate the signal visible in E3.
- M1–M4 mechanism families operate on a faster timescale (acute biological response, hours-to-weeks) than the R1–R3 resource-allocation families at the health-system scale (budget cycles, guideline revision cycles, years-to-decades), so mechanistic successes at the clinical scale can remain unfunded or unadopted long after the intervention evidence matures.
- R2 (opportunity-cost allocation) at the health-system/institutional scale constrains which M-families receive implementation trials at the study/trial scale, thereby obscuring the evidentiary status of under-resourced mechanisms — what appears as an E2 (indirect/inferential) gap at the meta-analytic scale may be an artifact of R2 decisions made two scales up.
- Research-system/funding scale operates on a slower priority-revision timescale than the study/trial scale, meaning that E1 evidence generated rapidly by new assay methods cannot propagate into revised E3 classifications until the slower funding and guideline infrastructure catches up — creating a cross-scale lag that makes the current evidential family assignments appear more stable than they are.
- Aggregate R3 (equity/access trade-off) signals at the health-system scale do not decompose back into recoverable M-family attributions at the clinical scale: a system-level finding that a resource allocation is inequitable cannot be traced to a specific intervention mechanism (M1 vs. M4) without study-scale data that is rarely collected for this purpose.


---


↓

## Step 7 — Outside-frame Trajectories (mode A)

> **Reading lens:** _The object as one element of a space of alternatives._

- [outside-original-frame] 
- [outside-original-frame] 
- [outside-original-frame] 
- [outside-original-frame] 
- [outside-original-frame] 
- [outside-original-frame] 
- [outside-original-frame] 


---


↓

## Step 8 — Stage-gated Roadmap

> **Reading lens:** _The object as a procedural artifact — a roadmap. NOTE: per the object drift audit (notes/elif_post_e2_object_drift_audit.md), Step 8 is the bifurcation point. The roadmap may describe world-actions OR analytical deliverables; the reader observes which._

- **A1**: Causal-layer decomposition (T7A-02 / T7A-07): Separate the bundled E×M×R triples into their distinct causal layers — epistemic (E), biological (M), and logistical (R) — and simultaneously audit whether E1, E2, and E3 evidence types are answering commensurable or incommensurable questions. This stage dissolves the assumption that a single joint causal model can take E, M, and R as co-equal inputs, and determines whether the H1-vs-H4 'evidence grade decisiveness' contest is a genuine empirical dispute or a category mistake.
  _gate:_ A written layer-attribution table exists in which each of E, M, and R has been assigned to exactly one causal layer, and at least one pair from {E1, E2, E3} has been formally classified as either commensurable or incommensurable via a pre-specified decision rule whose output is a binary verdict — proceed only when both the table and the classification verdict are complete and signed off by the designated analytic lead.
- **A2**: Mutual-exclusivity audit (T7A-01 / T7A-05): Test whether H1–H4 are logically mutually exclusive under all boundary conditions, or whether they describe complementary operating regimes that activate under distinct conditions — including temporal conditions. This stage applies the temporal reframing from T7A-05 to ask whether E×M×R co-evolve across the intervention lifecycle, making it possible that multiple hypotheses are simultaneously correct in different time-slices or activation regimes. The audit produces a compatibility matrix for H1–H4 and a set of boundary-condition signatures.
  _gate:_ A H1–H4 compatibility matrix is populated with a binary cell entry (mutually exclusive / compatible) for every hypothesis pair under at least two named boundary conditions (e.g., implementation onset vs. scale), AND at least one temporal boundary condition has been operationalized as a measurable threshold (e.g., a defined time-point or coverage level at which regime transition is testable) — proceed only when the matrix is complete and the temporal threshold is expressed as a decidable observable.
- **A3**: Actor-stratum and unit-of-analysis realignment (T7A-04 / T7A-06): Disaggregate the implicit single-actor assumption in H1–H4 by classifying the implementing actor mix into at least two strata (e.g., high-capacity vs. low-capacity sites), and re-examine whether mechanistic pathways M1–M4 are actor-contingent. Simultaneously, adjudicate whether the correct unit of analysis is the intervention, the study/site, or the mechanism-activation event, and flag any Step 5 falsification triggers that become category errors under a revised unit of analysis.
  _gate:_ At least two actor strata have been defined with pre-specified observable discriminators (e.g., a measurable site-capacity index cutoff), AND a unit-of-analysis decision memo has been produced that either (a) confirms the intervention level as appropriate with a documented rationale, or (b) names the revised unit and lists which Step 5 falsification triggers must be retired or respecified — proceed only when both deliverables exist as reviewable documents.
- **A4**: Cross-domain comparison-case analysis (T7A-03): Identify analogous E×M×R bundles in at least two adjacent intervention domains and determine whether the H1-vs-H4 tension (evidence grade vs. mechanism-resource fit) has appeared and been resolved in those domains. If the tension is a known artifact of underpowered within-domain designs, this stage shifts the primary inferential burden from internal hypothesis discrimination to external validity assessment and produces a calibrated prior for the resolution pathway.
  _gate:_ At least two comparison cases from distinct adjacent domains have been documented with their E×M×R bundle structures and resolution outcomes, AND a similarity-scoring rubric has been applied to each case yielding a numeric comparability score on a pre-defined scale — proceed only when both cases score above the pre-specified comparability threshold on that rubric, confirming their inferential relevance to the focal H1–H4 dispute.
- **A5**: Integrated roadmap synthesis and falsification-trigger revision: Consolidate outputs from A1–A4 into a revised hypothesis architecture that replaces or restructures H1–H4 as needed, re-specifies all Step 5 falsification triggers to be consistent with the confirmed causal layers, unit of analysis, actor strata, temporal boundary conditions, and evidence-type classifications, and produces a single decision package that either re-enters the original testing frame with amended hypotheses or formally routes to a redesigned data-collection protocol.
  _gate:_ Every surviving or revised hypothesis has exactly one falsification trigger expressed as a decidable observable signal, every retired trigger has a documented reason keyed to findings from stages A1–A4, and the decision package has received a formal review sign-off from the designated analytic lead and one independent reviewer — proceed to implementation or protocol redesign only when all three conditions are simultaneously met.


---


↓

## Step 9 — Verdict

> **Reading lens:** _The verdict's referent — whatever Step 8 produced. The Step 9 prompt presents Step 8's roadmap AS 'the proposed forward path' (governance_kernel.py:241-242). The reader observes whether this referent is still the input frame's deployment question._

- **verdict:** `constrain`
- **verdict_detail:** The Stage 8 roadmap (A1–A5) is authorized to proceed, but only under the following explicit constraints: (1) No stage may advance past its stated gate condition — each gate requires a signed, reviewable deliverable (layer-attribution table, compatibility matrix, unit-of-analysis memo, comparison-case rubric scores, and integrated decision package) before the next stage activates; partial completion does not satisfy a gate. (2) A1 is a strict prerequisite for A5, and A2–A4 are strict prerequisites for A5; A2, A3, and A4 may be executed in parallel with each other but not before A1 has closed its gate, because the causal-layer decomposition and commensurability verdict from A1 are load-bearing inputs for the compatibility matrix (A2), actor-stratum discriminators (A3), and domain-comparison scoring rubric (A4). (3) Any falsification trigger from Step 5 that is reclassified as a category error under the revised unit of analysis (A3) must be formally retired with documented rationale before the A5 synthesis proceeds — no trigger may be silently carried forward. (4) The confidence qualifier on this verdict is conditioned on the assumption that the prior-step outputs (Steps 1–8 markers) faithfully represent the analytic state of the underlying procedure; if any prior step output was provisional or contested, that state must be surfaced before A1 gate closure. (5) The designated analytic lead and independent reviewer roles named in the A5 gate must be identified and confirmed as distinct individuals prior to A3 gate closure, not at A5 time, to prevent a bottleneck. Authorization to proceed to implementation or protocol redesign is withheld until all A5 gate conditions are simultaneously met.


---


_The Panel renders the chain. It does not claim drift; the reader observes whether the object at each step is still recognizably about the object at the anchor. Per the object drift audit, ELIF v0.1's substrate does not itself enforce referential integrity from Step 9 back to Step 1._